Mabwell (shanghai) Bioscience Co., Ltd.
Clinical trials sponsored by Mabwell (shanghai) Bioscience Co., Ltd., explained in plain language.
-
First human tests begin for potential lung and tumor drug
Knowledge-focused CompletedThis study tested a new drug called 9MW3811 for the first time in humans. The main goal was to check if it is safe and how well it is tolerated in 32 healthy adults aged 18 to 55. Researchers gave a single dose and monitored for side effects, measuring how the drug moves through …
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
New injection tested in healthy people for future allergy and lung disease treatments
Knowledge-focused CompletedThis early-stage study tested the safety of an experimental injection called 9MW1911 in 48 healthy adults aged 18 to 65. The main goal was to see if the drug is safe and to find the highest dose people can tolerate without serious side effects. This study does not treat any disea…
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC